Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Century Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get IPSC alerts

About Morgan Conn, Ph.D.

Morgan Conn, Ph.D. is recorded as CFO at Century Therapeutics, Inc. (IPSC) since October 14, 2024. Century Therapeutics, Inc. reported in an 8-K filed July 7, 2025 that Morgan Conn, Ph.D. was terminated as Chief Financial Officer, effective July 11, 2025. Century Therapeutics, Inc. reported in an 8-K filed September 26, 2024 that Morgan Conn, Ph.D. was appointed Chief Financial Officer, effective October 14, 2024. Century Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Century Therapeutics, Inc. includes Brent Pfeiffenberger (CEO and Chairman), Gregory Russotti, Ph.D. (CEO), Brent Pfeiffenberger, Pharm.D. (Chairman) and 7 others.

“on July 1, 2025, the Board approved the departure of Morgan Conn, Ph.D. from his position as the Company's Chief Financial Officer, effective July 11, 2025”
Century Therapeutics, Inc. Form 8-K, filed July 7, 2025 · Read the filing
“On September 26, 2024, the Century Therapeutics, Inc. (the "Company") announced the appointment of Morgan Conn, Ph.D. to serve as the Company's Chief Financial Officer, effective October 14, 2024 (the "Effective Date").”
Century Therapeutics, Inc. Form 8-K, filed September 26, 2024 · Read the filing

Affiliation history

Company network

Leadership on record at Century Therapeutics, Inc.

Recent activity